rs777630688
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_018191.4(RCBTB1):βc.707delβ(p.Asn236ThrfsTer11) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000172 in 1,572,696 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.000033 ( 0 hom., cov: 30)
Exomes π: 0.000015 ( 0 hom. )
Consequence
RCBTB1
NM_018191.4 frameshift
NM_018191.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.71
Genes affected
RCBTB1 (HGNC:18243): (RCC1 and BTB domain containing protein 1) This gene encodes a protein with an N-terminal RCC1 domain and a C-terminal BTB (broad complex, tramtrack and bric-a-brac) domain. In rat, over-expression of this gene in vascular smooth muscle cells induced cellular hypertrophy. In rat, the C-terminus of RCBTB1 interacts with the angiotensin II receptor-1A. In humans, this gene maps to a region of chromosome 13q that is frequently deleted in B-cell chronic lymphocytic leukemia and other lymphoid malignancies. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 13-49552181-GT-G is Pathogenic according to our data. Variant chr13-49552181-GT-G is described in ClinVar as [Pathogenic]. Clinvar id is 224622.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-49552181-GT-G is described in Lovd as [Pathogenic]. Variant chr13-49552181-GT-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RCBTB1 | NM_018191.4 | c.707del | p.Asn236ThrfsTer11 | frameshift_variant | 7/13 | ENST00000378302.7 | NP_060661.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RCBTB1 | ENST00000378302.7 | c.707del | p.Asn236ThrfsTer11 | frameshift_variant | 7/13 | 1 | NM_018191.4 | ENSP00000367552 | P1 | |
RCBTB1 | ENST00000258646.3 | c.707del | p.Asn236ThrfsTer11 | frameshift_variant | 5/11 | 2 | ENSP00000258646 | P1 | ||
RCBTB1 | ENST00000490058.1 | n.71del | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152104Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
5
AN:
152104
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000113 AC: 22AN: 194238Hom.: 0 AF XY: 0.000106 AC XY: 11AN XY: 103326
GnomAD3 exomes
AF:
AC:
22
AN:
194238
Hom.:
AF XY:
AC XY:
11
AN XY:
103326
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000155 AC: 22AN: 1420592Hom.: 0 Cov.: 28 AF XY: 0.0000156 AC XY: 11AN XY: 703040
GnomAD4 exome
AF:
AC:
22
AN:
1420592
Hom.:
Cov.:
28
AF XY:
AC XY:
11
AN XY:
703040
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152104Hom.: 0 Cov.: 30 AF XY: 0.0000404 AC XY: 3AN XY: 74302
GnomAD4 genome
AF:
AC:
5
AN:
152104
Hom.:
Cov.:
30
AF XY:
AC XY:
3
AN XY:
74302
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
RCBTB1-related retinopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | May 22, 2022 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.012%). Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The homozygous variant is shared with the affected family members (3billion dataset). The variant has been reported to be associated with RCBTB1 related disorder (ClinVar ID: VCV000224622). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Exudative retinopathy Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | Laboratory of Human Molecular Genetics, Department of Medical Research, Taipei Veterans General Hospital | - | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 19, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 224622). This premature translational stop signal has been observed in individual(s) with Coats disease and retinal dystrophy (PMID: 26908610, 31494449). This variant is present in population databases (rs777630688, gnomAD 0.2%). This sequence change creates a premature translational stop signal (p.Asn236Thrfs*11) in the RCBTB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RCBTB1 are known to be pathogenic (PMID: 31494449). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at